| NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name | Strength | SEER*Rx Category | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 71335-2974-03 | 71335-2974 | Ondansetron | Ondansetron | 8.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Apr 16, 2026 | In Use | |
| 52536-0341-05 | 52536-0341 | Lomustine | Lomustine | 40.0 mg/1 | Chemotherapy | Alkylating Agent | Nitrosourea | Oral | Apr 15, 2026 | In Use | |
| 52536-0340-05 | 52536-0340 | Lomustine | Lomustine | 10.0 mg/1 | Chemotherapy | Alkylating Agent | Nitrosourea | Oral | Apr 15, 2026 | In Use | |
| 52536-0342-05 | 52536-0342 | Lomustine | Lomustine | 100.0 mg/1 | Chemotherapy | Alkylating Agent | Nitrosourea | Oral | Apr 15, 2026 | In Use | |
| 25021-0471-66 | 25021-0471 | Fulvestrant | Fulvestrant | 50.0 mg/mL | Hormonal Therapy | Estrogen Receptor Antagonist | Intramuscular | Apr 15, 2026 | In Use | ||
| 48433-0050-03 | 48433-0050 | Imatinib | Imatinib Mesylate | 400.0 mg/1 | Chemotherapy | Tyrosine Kinase Inhibitor | BCR-ABL | Oral | Apr 10, 2026 | In Use | |
| 48433-0049-03 | 48433-0049 | Imatinib | Imatinib Mesylate | 100.0 mg/1 | Chemotherapy | Tyrosine Kinase Inhibitor | BCR-ABL | Oral | Apr 10, 2026 | In Use | |
| 68001-0705-27 | 68001-0705 | Paclitaxel | Paclitaxel | 6.0 mg/mL | Chemotherapy | Antimitotic Agent | Taxane | Intravenous | Apr 9, 2026 | In Use | |
| 71335-9715-06 | 71335-9715 | PREDNISONE | Prednisone | 50.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Apr 9, 2026 | In Use | |
| 71335-9715-04 | 71335-9715 | PREDNISONE | Prednisone | 50.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Apr 9, 2026 | In Use | |
| 71335-9715-08 | 71335-9715 | PREDNISONE | Prednisone | 50.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Apr 9, 2026 | In Use | |
| 72189-0673-21 | 72189-0673 | Prednisone D/P | Prednisone D/P | 5.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Apr 9, 2026 | In Use | |
| 71335-9715-05 | 71335-9715 | PREDNISONE | Prednisone | 50.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Apr 9, 2026 | In Use | |
| 16729-0697-06 | 16729-0697 | Lenalidomide | Lenalidomide | 25.0 mg/1 | Immunotherapy | Immunomodulator | Thalidomide Analog | Oral | Apr 8, 2026 | In Use | |
| 16729-0692-09 | 16729-0692 | Lenalidomide | Lenalidomide | 2.5 mg/1 | Immunotherapy | Immunomodulator | Thalidomide Analog | Oral | Apr 8, 2026 | In Use | |
| 39822-2080-01 | 39822-2080 | Eribulin mesylate | ERIBULIN MESYLATE | 0.5 mg/mL | Chemotherapy | Antimitotic Agent | Furopyrans | Intravenous | Apr 7, 2026 | In Use | |
| 72789-0473-18 | 72789-0473 | PredniSONE | PredniSONE Tablets, USP, 20 mg | 20.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Apr 6, 2026 | In Use | |
| 71335-2974-09 | 71335-2974 | Ondansetron | Ondansetron | 8.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Apr 6, 2026 | In Use | |
| 70518-4038-08 | 70518-4038 | PREDNISONE | Prednisone | 10.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Apr 3, 2026 | In Use | |
| 85766-0194-10 | 85766-0194 | Triamcinolone Acetonide | Triamcinolone Acetonide | 400.0 mg/10mL | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Intra-articular, Intramuscular | Apr 1, 2026 | In Use | |
| 85766-0195-05 | 85766-0195 | Methylprednisolone acetate | Methylprednisolone acetate | 40.0 mg/mL | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Intra-articular, Intralesional, Intramuscular, Intrasynovial, Soft Tissue | Apr 1, 2026 | In Use | |
| 70748-0273-01 | 70748-0273 | Pegfilgrastim-unne | ARMLUPEG | 6.0 mg/.6mL | Ancillary Therapy | Immunostimulant | Granulocyte Colony-Stimulating Factor | Subcutaneous | Apr 1, 2026 | In Use | |
| 83831-0144-05 | 83831-0144 | Etoposide | Avopef | 100.0 mg/5mL | Chemotherapy | Plant Alkaloid | Epipodophyllotoxins | Intravenous | Apr 1, 2026 | In Use | |
| 55513-0099-01 | 55513-0099 | Pegfilgrastim | Neulasta | 4.0 mg/.4mL | Ancillary Therapy | Immunostimulant | Granulocyte Colony-Stimulating Factor | Subcutaneous | Mar 31, 2026 | In Use | |
| 55154-2581-00 | 55154-2581 | Prednisone | Prednisone | 20.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Mar 30, 2026 | In Use |
Found 12482 results — Export these results
Home